Wells Fargo & Company »

Elevation Oncology shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Elevation Oncology (ELEV) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Elevation Oncology

Tip: Access up to 7 years of quarterly data

All positions including Elevation Oncology held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elevation Oncology by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $129 241 0.54
2023-09-30 $152 229 0.66
2023-06-30 $148 98 1.52
2022-12-31 $86 90 0.96
2022-09-30 $0 88 0.00
2022-06-30 $0 42 0.00
2022-03-31 $0 39 0.00
2021-12-31 $0 38 0.00
2021-09-30 $0 38 0.00